StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3024% below fair value
$17.06−1.42 (-7.68%)

Close on Nov 17, 2026Market cap $1.19BP/E –Yield –

Tandem Diabetes Care ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Tandem Diabetes Care's ebitda for the twelve months ending Jun 30, 2026 was -$27.83M. For fiscal 2025 it was -$169.59M. The highest annual figure on record is $36.50M in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$169.59M–
FY2024Dec 31, 2024-$82.52M–
FY2023Dec 31, 2023-$217.52M–
FY2022Dec 31, 2022-$78.52M-315.1%
FY2021Dec 31, 2021$36.50M+1363.4%
FY2020Dec 31, 2020$2.49M–
FY2019Dec 31, 2019-$10.65M–
FY2018Dec 31, 2018-$38.81M–
FY2017Dec 31, 2017-$56.08M–
FY2016Dec 31, 2016-$72.56M–
FY2015Dec 31, 2015-$64.18M–
FY2014Dec 31, 2014-$71.28M–
FY2013Dec 31, 2013-$46.27M–
FY2012Dec 31, 2012-$31.02M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.32M–
Q1 FY2026Mar 31, 2026-$12.93M–
Q4 FY2025Dec 31, 2025$12.79M+249.0%
Q3 FY2025Sep 30, 2025-$18.37M–
Q2 FY2025Jun 30, 2025-$47.44M–
Q1 FY2025Mar 31, 2025-$116.57M–
Q4 FY2024Dec 31, 2024$3.66M–
Q3 FY2024Sep 30, 2024-$21.88M–
Q2 FY2024Jun 30, 2024-$26.67M–
Q1 FY2024Mar 31, 2024-$37.64M–
Q4 FY2023Dec 31, 2023-$31.03M–
Q3 FY2023Sep 30, 2023-$27.52M–
Q2 FY2023Jun 30, 2023-$34.54M–
Q1 FY2023Mar 31, 2023-$124.42M–
Q4 FY2022Dec 31, 2022-$14.14M-186.9%
Q3 FY2022Sep 30, 2022-$43.99M-495.5%
Q2 FY2022Jun 30, 2022-$8.69M-197.9%
Q1 FY2022Mar 31, 2022-$11.71M-4821.8%
Q4 FY2021Dec 31, 2021$16.26M-26.4%
Q3 FY2021Sep 30, 2021$11.12M+461.6%
Q2 FY2021Jun 30, 2021$8.87M–
Q1 FY2021Mar 31, 2021$248.00K–
Q4 FY2020Dec 31, 2020$22.09M+483.4%
Q3 FY2020Sep 30, 2020$1.98M–
Q2 FY2020Jun 30, 2020-$9.83M–
Q1 FY2020Mar 31, 2020-$11.74M–
Q4 FY2019Dec 31, 2019$3.79M+86.7%
Q3 FY2019Sep 30, 2019-$4.52M–
Q2 FY2019Jun 30, 2019-$357.00K–
Q1 FY2019Mar 31, 2019-$9.56M–
Q4 FY2018Dec 31, 2018$2.03M–
Q3 FY2018Sep 30, 2018-$14.25M–
Q2 FY2018Jun 30, 2018-$12.59M–
Q1 FY2018Mar 31, 2018-$13.99M–
Q4 FY2017Dec 31, 2017-$7.45M–
Q3 FY2017Sep 30, 2017-$11.45M–
Q2 FY2017Jun 30, 2017-$17.38M–
Q1 FY2017Mar 31, 2017-$19.80M–
Q4 FY2016Dec 31, 2016-$11.87M–
Q3 FY2016Sep 30, 2016-$27.12M–

More Tandem Diabetes Care figures

See a number that looks wrong?